Abstract
Free-living amoebae in water supply systems harbor bacterial endosymbionts. Legionella pneumophila, the agent of Legionnaires' disease, was one of the first agents that was demonstrated to survive and multiply within amoebae. Similar bacteria, termed Legionella-like amoebal pathogens (LLAP's), were subsequently described and implicated in human respiratory tract infections. Amoebal co-cultivation/enrichment techniques and molecular methods (e.g., PCR) have elucidated a variety of alphaproteobacteria (e.g., Afipia, Bosea, Mesorhizobium, and Rasbobacterium species) and Chlamydia-like bacteria (e.g., Parachlamydia, Simkania, Protochlamydia, and Waddlia species) within free-living amoebae in hospital water systems. These agents are also able to survive and multiply within macrophages, pneumocytes, and lung fibroblasts. Sero-epidemiological studies and application of molecular technology to clinical specimens have revealed these agents as rare causes of community- and health care-associated pneumonia, particularly among immunocompromised patients. Additional studies have implicated these agents in other infectious processes. This article reviews these newly described microorganisms and the evidence for their roles in human infections and disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Medical Microbiology Supplements
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
